INBIOGEN Co., Ltd. (KRX:101140)
12,630
-920 (-6.79%)
At close: Apr 30, 2025
INBIOGEN Revenue
In the year 2024, INBIOGEN had annual revenue of 7.04B KRW with 12.82% growth. INBIOGEN had revenue of 2.17B in the quarter ending December 31, 2024, with 38.75% growth.
Revenue
7.04B
Revenue Growth
+12.82%
P/S Ratio
17.91
Revenue / Employee
171.73M
Employees
41
Market Cap
126.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.04B | 800.26M | 12.82% |
Dec 31, 2023 | 6.24B | -4.18B | -40.10% |
Dec 31, 2022 | 10.42B | -61.30M | -0.58% |
Dec 31, 2021 | 10.48B | 263.11M | 2.58% |
Dec 31, 2020 | 10.22B | 422.51M | 4.31% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Hyundai Motor Company | 178.98T |
Kia Corporation | 107.45T |
Hyundai Mobis Co.,Ltd | 57.24T |
COWAY | 4,310.14B |
Hanjin Kal | 292.16B |
Hankook Tire & Technology | 9,411.95B |
Kangwon Land | 1,426.86B |
F&F Co., Ltd | 1,896.01B |
INBIOGEN News
- 4 weeks ago - ARTIS REAL ESTATE INVESTMENT TRUST ANNOUNCES TIMING OF RELEASE OF Q1-25 RESULTS AND CONFERENCE CALL - Benzinga